Inprostate cancer, the tumor-promoting effect of EZH2 is attributed to itsinhibitory action on the transcription of multiple genes, includingDAB2IP, ADRB2, SLIT2, andE-cadherin (Yu etal., 2007; Minet al., 2010; Yuet al., 2010). The gene discussed is CDH17; the disease is cancer.